US Stock MarketDetailed Quotes

TCBP TC BioPharm

Watchlist
  • 1.3100
  • -0.1200-8.39%
Close Mar 28 16:00 ET
  • 1.3199
  • +0.0099+0.76%
Post 19:53 ET
3.18MMarket Cap-192P/E (TTM)

About TC BioPharm Company

TC Biopharm (Holdings) Plc is a clinical-stage biopharmaceutical company, which engages in the development of novel immunotherapy products based on its proprietary allogeneic gamma delta T cell platform. The company was founded by Michael Leek and Angela Scott in 2013 and is headquartered in Motherwell, the United Kingdom.

Company Profile

SymbolTCBP
Company NameTC BioPharm
Listing Date02/11/2022
Issue Price4.24
Founded2013
CEOMr. Bryan Kobel
MarketNASDAQ
Employees77
Securities TypeDR
ADS Ratio1.0 : 20.0
Fiscal Year Ends12-31
AddressMaxim Park 1,2 Parklands Way,Holytown
CityMotherwell
ProvinceNK
CountryUnited Kingdom of Great Britain and Northern Ireland (the)
Zip CodeML1 4WR
Phone44-141-433-7557

Company Executives

  • Name
  • Position
  • Salary
  • Bryan Kobel
  • Chief Executive Officer and Director
  • --
  • Martin Thorp
  • Chief Financial Officer and Director
  • --
  • Edward Niemczyk
  • Chairman of the Board
  • --
  • Dr. Mark Bonyhadi
  • Director
  • --
  • Arlene M. Morris
  • Independent Director
  • --
  • Anthony James Culverwell
  • Independent Director
  • --

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
%Chg